MMP9 and neoplasm: Further experimental results highlighted that luteolin significantly reduced tumor growth of A375 cells in a mouse xenograft model, confirming that the antitumor activity is derived from down-regulation of MMP-2 and MMP-9 expression through the PI3K/Akt pathway [97].